Proteomic Analysis of Artemisia Annua--towards Elucidating the Biosynthetic Pathways of the Antimalarial Pro-drug Artemisinin

Overview

Journal BMC Plant Biol

Publisher Biomed Central

Specialty Biology

Date 2015 Jul 10

PMID 26156581

Citations 19

Authors

Laura Bryant

Brian Flatley

Chhaya Patole

Geoffrey D Brown

Rainer Cramer

Affiliations

Soon will be listed here.

Abstract

Background: MS-based proteomics was applied to the analysis of the medicinal plant Artemisia annua, exploiting a recently published contig sequence database (Graham et al. (2010) Science 327, 328-331) and other genomic and proteomic sequence databases for comparison. A. annua is the predominant natural source of artemisinin, the precursor for artemisinin-based combination therapies (ACTs), which are the WHO-recommended treatment for P. falciparum malaria.

Results: The comparison of various databases containing A. annua sequences (NCBInr/viridiplantae, UniProt/viridiplantae, UniProt/A. annua, an A. annua trichome Trinity contig database, the above contig database and another A. annua EST database) revealed significant differences in respect of their suitability for proteomic analysis, showing that an organism-specific database that has undergone extensive curation, leading to longer contig sequences, can greatly increase the number of true positive protein identifications, while reducing the number of false positives. Compared to previously published data an order-of-magnitude more proteins have been identified from trichome-enriched A. annua samples, including proteins which are known to be involved in the biosynthesis of artemisinin, as well as other highly abundant proteins, which suggest additional enzymatic processes occurring within the trichomes that are important for the biosynthesis of artemisinin.

Conclusions: The newly gained information allows for the possibility of an enzymatic pathway, utilizing peroxidases, for the less well understood final stages of artemisinin's biosynthesis, as an alternative to the known non-enzymatic in vitro conversion of dihydroartemisinic acid to artemisinin. Data are available via ProteomeXchange with identifier PXD000703.

Citing Articles

Integration of CRISPR/Cas9 with multi-omics technologies to engineer secondary metabolite productions in medicinal plant: Challenges and Prospects.

Borah A, Singh S, Chattopadhyay R, Kaur J, Bari V Funct Integr Genomics. 2024; 24(6):207.

PMID: 39496976 DOI: 10.1007/s10142-024-01486-w.

Strategies on biosynthesis and production of bioactive compounds in medicinal plants.

Guo M, Lv H, Chen H, Dong S, Zhang J, Liu W Chin Herb Med. 2024; 16(1):13-26.

PMID: 38375043 PMC: 10874775. DOI: 10.1016/j.chmed.2023.01.007.

High variability of perezone content in rhizomes of wild plants, environmental factors related, and proteomic analysis.

Garcia Mendez M, Encarnacion-Guevara S, Martinez Batallar A, Gomez-Caudillo L, Bru-Martinez R, Martinez Marquez A PeerJ. 2023; 11:e16136.

PMID: 38025722 PMC: 10656900. DOI: 10.7717/peerj.16136.

From Plant to Yeast-Advances in Biosynthesis of Artemisinin.

Zhao L, Zhu Y, Jia H, Han Y, Zheng X, Wang M Molecules. 2022; 27(20).

PMID: 36296479 PMC: 9609949. DOI: 10.3390/molecules27206888.

Metabolic Perturbation and Synthetic Biology Strategies for Plant Terpenoid Production-An Updated Overview.

Mani V, Park S, Kim J, Lee S, Lee K Plants (Basel). 2021; 10(10).

PMID: 34685985 PMC: 8539415. DOI: 10.3390/plants10102179.

References

Chang Y, Song S, Park S, Kim S . Amorpha-4,11-diene synthase of Artemisia annua: cDNA isolation and bacterial expression of a terpene synthase involved in artemisinin biosynthesis. Arch Biochem Biophys. 2001; 383(2):178-84. DOI: 10.1006/abbi.2000.2061. View

Gershenzon J, McCaskill D, Rajaonarivony J, Mihaliak C, Karp F, Croteau R . Isolation of secretory cells from plant glandular trichomes and their use in biosynthetic studies of monoterpenes and other gland products. Anal Biochem. 1992; 200(1):130-8. DOI: 10.1016/0003-2697(92)90288-i. View

Teoh K, Polichuk D, Reed D, Nowak G, Covello P . Artemisia annua L. (Asteraceae) trichome-specific cDNAs reveal CYP71AV1, a cytochrome P450 with a key role in the biosynthesis of the antimalarial sesquiterpene lactone artemisinin. FEBS Lett. 2006; 580(5):1411-6. DOI: 10.1016/j.febslet.2006.01.065. View

Ro D, Paradise E, Ouellet M, Fisher K, Newman K, Ndungu J . Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature. 2006; 440(7086):940-3. DOI: 10.1038/nature04640. View

Chang M, Eachus R, Trieu W, Ro D, Keasling J . Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol. 2007; 3(5):274-7. DOI: 10.1038/nchembio875. View

Kong J, Cheng K, Wang L, Zheng X, Dai J, Zhu P . [Increase of copy number of HMG-CoA reductase and FPP synthase genes improves the amorpha4,11-diene production in engineered yeast]. Yao Xue Xue Bao. 2008; 42(12):1314-9. View

Ansong C, Purvine S, Adkins J, Lipton M, Smith R . Proteogenomics: needs and roles to be filled by proteomics in genome annotation. Brief Funct Genomic Proteomic. 2008; 7(1):50-62. DOI: 10.1093/bfgp/eln010. View

Zhang Y, Teoh K, Reed D, Maes L, Goossens A, Olson D . The molecular cloning of artemisinic aldehyde Delta11(13) reductase and its role in glandular trichome-dependent biosynthesis of artemisinin in Artemisia annua. J Biol Chem. 2008; 283(31):21501-8. DOI: 10.1074/jbc.M803090200. View

Wang W, Wang Y, Zhang Q, Qi Y, Guo D . Global characterization of Artemisia annua glandular trichome transcriptome using 454 pyrosequencing. BMC Genomics. 2009; 10:465. PMC: 2763888. DOI: 10.1186/1471-2164-10-465. View

10.

Graham I, Besser K, Blumer S, Branigan C, Czechowski T, Elias L . The genetic map of Artemisia annua L. identifies loci affecting yield of the antimalarial drug artemisinin. Science. 2010; 327(5963):328-31. DOI: 10.1126/science.1182612. View

11.

Fidock D . Drug discovery: Priming the antimalarial pipeline. Nature. 2010; 465(7296):297-8. DOI: 10.1038/465297a. View

12.

Van Noorden R . Demand for malaria drug soars. Nature. 2010; 466(7307):672-3. DOI: 10.1038/466672a. View

13.

Bindschedler L, Cramer R . Fully automated software solution for protein quantitation by global metabolic labeling with stable isotopes. Rapid Commun Mass Spectrom. 2011; 25(11):1461-71. DOI: 10.1002/rcm.4872. View

14.

Bindschedler L, McGuffin L, Burgis T, Spanu P, Cramer R . Proteogenomics and in silico structural and functional annotation of the barley powdery mildew Blumeria graminis f. sp. hordei. Methods. 2011; 54(4):432-41. DOI: 10.1016/j.ymeth.2011.03.006. View

15.

Farhi M, Marhevka E, Ben-Ari J, Algamas-Dimantov A, Liang Z, Zeevi V . Generation of the potent anti-malarial drug artemisinin in tobacco. Nat Biotechnol. 2011; 29(12):1072-4. DOI: 10.1038/nbt.2054. View

16.

Wu T, Wang Y, Guo D . Investigation of glandular trichome proteins in Artemisia annua L. using comparative proteomics. PLoS One. 2012; 7(8):e41822. PMC: 3414485. DOI: 10.1371/journal.pone.0041822. View

17.

Lange B, Turner G . Terpenoid biosynthesis in trichomes--current status and future opportunities. Plant Biotechnol J. 2012; 11(1):2-22. DOI: 10.1111/j.1467-7652.2012.00737.x. View

18.

Paddon C, Westfall P, Pitera D, Benjamin K, Fisher K, McPhee D . High-level semi-synthetic production of the potent antimalarial artemisinin. Nature. 2013; 496(7446):528-32. DOI: 10.1038/nature12051. View

19.

Soetaert S, Van Neste C, Vandewoestyne M, Head S, Goossens A, Van Nieuwerburgh F . Differential transcriptome analysis of glandular and filamentous trichomes in Artemisia annua. BMC Plant Biol. 2013; 13:220. PMC: 3878173. DOI: 10.1186/1471-2229-13-220. View

20.

Yang K, Rashidi Monfared S, Monafared R, Wang H, Lundgren A, Brodelius P . The activity of the artemisinic aldehyde Δ11(13) reductase promoter is important for artemisinin yield in different chemotypes of Artemisia annua L. Plant Mol Biol. 2015; 88(4-5):325-40. DOI: 10.1007/s11103-015-0284-3. View